Debiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates, develops its products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing. Debio comprises five synergistic companies, Debiopharm S.A., Debiovision, Debio Recherche Pharmaceutique SA (Debio R.P.), Debioclinic SA and Debioinnovation SA.

Acquired Companies: H3 Pharma